City of Hope has long been a leader in myeloma research, including promising new combinations of chemotherapy drugs, stem cell transplant procedures and radiation treatments. With our extensive program of clinical trials, City of Hope can provide our patients access to novel therapies that are not yet available elsewhere.
For patients with relapsed myeloma, multiple treatment options are available, including both standard drugs and novel agents that are being tested in clinical trials. City of Hope is part of the Multiple Myeloma Research Consortium, a small group of institutions collaborating to bring new drugs to clinical trials.
To learn more about our clinical trials program, click here.